American scientists have developed the first ever high-throughput, genome-scale, imaging-based platform to investigate protein stability, providing novel therapeutic possibilities for treating HIV, Alzheimerâ€™s disease and cancer. The study, published on Tuesday in the journal Cell Reports, involved a platform named Global Arrayed Protein Stability Analysis (GAPSA). GAPSA has been used to find host proteins targeted by the HIV-1 accessory protein Vpu, which allows the virus to replicate. Do you have something awesome to share with the world? Click here to share Do you ever have any question about anything you wish to ask and get answer? Click here to ask Follow us on twitter @NigeriaTodayNG Also, Like us on facebook This post was syndicated from The NEWS. Click here to read the full text on the original website.